Nano Dimension signed a term sheet with Infinite Epigenetics to create a public preventive health company. The deal follows a strategic review of 20 different firms. This venture combines capital with AI-driven diagnostics to target long-term value. Practitioners should view this as a niche pivot toward biotech rather than a broad AI infrastructure play.